BEONE MEDICINES LTD. (ONC) Operating Margin
- Operating margin · 12 months: Value 15.06%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 15.06% | Operating income / revenue. Period ending 2026-06-30. $923.10M ÷ $6.13B × 100 ≈ 15.06% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 923.10M USD | Operating Income (Loss) |
| Revenue | 6.13B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 2.29B USD | Research and Development Expense |
| Selling, general and administration | 2.23B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $923.10M | $6.13B | (m) | $2.29B | $2.23B | 15.06% |
| 2026-03-31 | $685.94M | $5.74B | (m) | $2.21B | $2.18B | 11.95% |
| 2025-12-31 | $447.14M | $5.34B | (m) | $2.15B | $2.08B | 8.37% |
| 2025-09-30 | $182.68M | $4.97B | (m) | $2.07B | $2.03B | 3.67% |
| 2025-06-30 | $-100.70M | $4.56B | (m) | $2.04B | $1.96B | -2.21% |
| 2025-03-31 | $-295.75M | $4.18B | (m) | $1.97B | $1.86B | -7.08% |
| 2024-12-31 | $-568.20M | $3.81B | (m) | $1.95B | $1.83B | -14.91% |
| 2024-09-30 | $-872.57M | $3.32B | (m) | $1.91B | $1.74B | -26.31% |
| 2024-06-30 | $-886.27M | $3.10B | (m) | $1.86B | $1.65B | -28.62% |
| 2024-03-31 | $-1.10B | $2.76B | (m) | $1.83B | $1.60B | -39.74% |
| 2023-12-31 | $-1.21B | $2.46B | (m) | $1.78B | $1.50B | -49.12% |
| 2023-09-30 | $-1.29B | $2.20B | $347.61M | $1.73B | $1.42B | -58.63% |
| 2023-06-30 | $-1.60B | $1.81B | $327.84M | $1.70B | $1.38B | -88.19% |
| 2023-03-31 | $-1.72B | $1.56B | $303.03M | $1.66B | $1.31B | -110.31% |
| 2022-12-31 | $-1.79B | $1.42B | $286.48M | $1.64B | $1.28B | -126.40% |
| 2022-09-30 | $-1.89B | (m) | $261.50M | $1.62B | $1.26B | (m) |
| 2022-06-30 | $-1.92B | (m) | $232.37M | $1.55B | $1.20B | (m) |
| 2022-03-31 | $-1.95B | (m) | $197.46M | $1.53B | $1.10B | (m) |
| 2021-12-31 | $-1.44B | (m) | $164.91M | $1.46B | $990.12M | (m) |
| 2021-09-30 | $-1.35B | $1.06B | $137.44M | $1.38B | $891.83M | -127.25% |
| 2021-06-30 | $-1.33B | $947.04M | $111.15M | $1.38B | $783.44M | -140.41% |
| 2021-03-31 | $-1.21B | $862.69M | $89.19M | $1.31B | $675.20M | -140.70% |
| 2020-12-31 | $-1.66B | $308.87M | $70.66M | $1.29B | $600.18M | -536.69% |
| 2020-09-30 | $-1.56B | $265.67M | $67.56M | $1.22B | $535.32M | -587.51% |
| 2020-06-30 | $-1.43B | $224.73M | $66.55M | $1.11B | $479.49M | -637.63% |
| 2020-03-31 | $-1.16B | $402.44M | $70.08M | $1.05B | $437.69M | -288.22% |
| 2019-12-31 | $-959.89M | $428.21M | $71.19M | $927.34M | $388.25M | -224.16% |
| 2019-09-30 | $-852.66M | $429.99M | $62.40M | $901.54M | $317.38M | -198.30% |
| 2019-06-30 | $-691.50M | $434.05M | $51.00M | $812.16M | $261.20M | -159.31% |
| 2019-03-31 | $-768.72M | $243.51M | $39.42M | $747.66M | $224.12M | -315.68% |
| 2018-12-31 | $-705.77M | $198.22M | $28.70M | $679.00M | $195.38M | -356.05% |
| 2018-09-30 | $-528.76M | $157.72M | (m) | $512.88M | $150.31M | -335.24% |
| 2018-06-30 | $-262.75M | $323.74M | (m) | $452.95M | $117.13M | -81.16% |
| 2018-03-31 | $-157.72M | (m) | (m) | $335.94M | $82.75M | (m) |
| 2017-12-31 | $-98.46M | $238.39M | (m) | $269.02M | $62.60M | -41.30% |
| 2017-09-30 | $-31.93M | $220.21M | (m) | $206.61M | (m) | -14.50% |
| 2017-06-30 | $-181.66M | (m) | (m) | $149.06M | (m) | (m) |
| 2017-03-31 | $-148.27M | (m) | (m) | $122.93M | (m) | (m) |
| 2016-12-31 | $-117.06M | $1.07M | (m) | $98.03M | (m) | -10940.19% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-56.74M | $8.82M | (m) | $58.25M | (m) | -643.66% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-15.76M | $13.04M | (m) | $21.86M | (m) | -120.88% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.